Back
Day Range
$11.52
$11.52
52-Week Range
$11.52
$13.40
Volume
120
50D / 200D Avg
$11.52
/
$11.52
Prev Close
$11.52
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 0.1 | 0.4 |
| P/B | 0.0 | 2.9 |
| ROE % | 11.9 | 3.7 |
| Net Margin % | 12.1 | 3.8 |
| Rev Growth 5Y % | 0.2 | 10.0 |
| D/E | 0.5 | 0.2 |
Key Takeaways
Revenue grew 0.24% annually over 5 years — modest growth
Earnings grew 67.49% over the past year
ROE of 11.87% — decent returns on equity
Generating 337.00M in free cash flow
P/E of 0.06 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 6.64%
Growth
Revenue Growth (5Y)
0.24%
Revenue (1Y)6.88%
Earnings (1Y)67.49%
FCF Growth (3Y)N/A
Quality
Return on Equity
11.87%
ROIC5.88%
Net Margin12.13%
Op. Margin11.01%
Safety
Debt / Equity
0.53
Current Ratio1.95
Interest Coverage20.03
Valuation
P/E Ratio
0.06
P/B Ratio0.01
EV/EBITDA2.59
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6.88% | Revenue Growth (3Y) | -2.87% |
| Earnings Growth (1Y) | 67.49% | Earnings Growth (3Y) | 34.57% |
| Revenue Growth (5Y) | 0.24% | Earnings Growth (5Y) | 16.76% |
| Profitability | |||
| Revenue (TTM) | 189.02B | Net Income (TTM) | 22.94B |
| ROE | 11.87% | ROA | 6.47% |
| Gross Margin | 29.81% | Operating Margin | 11.01% |
| Net Margin | 12.13% | Free Cash Flow (TTM) | 337.00M |
| ROIC | 5.88% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.53 | Current Ratio | 1.95 |
| Interest Coverage | 20.03 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 0.06 | P/B Ratio | 0.01 |
| P/S Ratio | 0.01 | PEG Ratio | -0.27 |
| EV/EBITDA | 2.59 | Dividend Yield | 0.02% |
| Market Cap | 1.33B | Enterprise Value | 53.88B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 189.02B | 176.86B | 200.34B | 193.82B | 187.22B |
| Net Income | 22.94B | 13.70B | 12.67B | -28.27B | 12.34B |
| EPS (Diluted) | 184.45 | 311.80 | 96.20 | -645.54 | 281.52 |
| Gross Profit | 56.35B | 54.32B | 62.63B | 66.65B | 72.43B |
| Operating Income | 20.81B | 18.62B | 16.39B | -4.45B | 18.89B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 354.62B | 382.02B | 364.17B | 349.50B | 393.34B |
| Total Liabilities | 180.77B | 163.99B | 151.43B | 149.42B | 152.59B |
| Shareholders' Equity | 173.85B | 212.66B | 201.64B | 190.07B | 218.28B |
| Total Debt | 91.34B | 82.89B | 77.07B | 71.23B | 71.85B |
| Cash & Equivalents | 38.79B | 26.37B | 33.08B | 47.72B | 54.27B |
| Current Assets | 200.82B | 239.99B | 205.35B | 202.12B | 205.67B |
| Current Liabilities | 102.82B | 77.35B | 85.15B | 88.84B | 80.45B |